uracil has been researched along with Jaundice, Cholestatic in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Excerpt | Relevance | Reference |
---|---|---|
"The patient diagnosed as recurrent pancreatic cancer was treated with UFT combined gemcitabine (GEM) chemotherapy." | 1.33 | [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease]. ( Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yajima, T | 1 |
Furukawa, Y | 1 |
Ishii, Y | 1 |
Hattori, Y | 1 |
Matsumoto, N | 1 |
Yamamoto, M | 1 |
Yamaoka, Y | 1 |
Fujihara, M | 1 |
Fujita, M | 1 |
Kuniki, H | 1 |
Sunagozaka, H | 1 |
Yamashita, T | 1 |
Kagaya, T | 1 |
Kato, Y | 1 |
Kaneko, S | 1 |
2 other studies available for uracil and Jaundice, Cholestatic
Article | Year |
---|---|
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Ad | 2004 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Co | 2006 |